Kendall Law Group Investigates Medco Health Solutions, Inc.

Kendall Law Group, led by former federal judge Joe Kendall, is investigating Medco Health Solutions, Inc. (NYSE: MHS) for shareholders in connection with the proposed acquisition by Express Scripts, Inc. The national securities firm’s investigation seeks to determine whether Medco and its Board breached their fiduciary duties by entering into the agreement without properly shopping for a deal that would provide better value for shareholders. If you are a Medco shareholder and would like additional information about your rights, contact the Kendall Law Group at 877-744-3728 or by email at [e-mail].

On July 21, 2011, the companies announced the definitive merger agreement under which Medco would be acquired by Express Scripts, in a transaction valued at approximately $29.1 billion. Under the terms of the agreement, Medco stockholders will receive $28.80 in cash and 0.81 Express Scripts shares (NASDAQ: ESRX) for each share of Medco/MHS common stock held. The offer values Medco at $71.36 a share, which represents a 28% premium to Medco’s Wednesday closing price of $55.78. According to Thompson/First Call, analysts have set a price target as high as $77.00 per share for Medco’s stock. The firm’s investigation seeks to determine whether Medco and its Board undertook a fair process in negotiating the deal.

Kendall Law Group was founded by a former federal judge, includes a former United States Attorney, prosecutors and securities lawyers who are experienced in complex securities litigation. The firm has been counsel in numerous merger and acquisition cases nationwide, including some of the largest transactions in the United States.